Selected article for: "active vitro and acute respiratory syndrome"
Author: Ekins, Sean; Mottin, Melina; Ramos, Paulo R.P.S.; Sousa, Bruna K.P.; Neves, Bruno Junior; Foil, Daniel H.; Zorn, Kimberley M.; Braga, Rodolpho C.; Coffee, Megan; Southan, Christopher; Puhl, Ana C.; Andrade, Carolina Horta
Title: Déjà vu: Stimulating open drug discovery for SARS-CoV-2
  • Cord-id: mwf0fjua
  • Document date: 2020_4_19
    • ID: mwf0fjua
    Snippet: In the past decade we have seen two major Ebola virus outbreaks in Africa, the Zika virus in Brazil and the Americas and the current pandemic of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There is a strong sense of déjà vu because there are still no effective treatments. In the COVID-19 pandemic, despite being a new virus, there are already drugs suggested as active in in vitro assays that are being repurposed in clinical trials. Pro
    Document: In the past decade we have seen two major Ebola virus outbreaks in Africa, the Zika virus in Brazil and the Americas and the current pandemic of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There is a strong sense of déjà vu because there are still no effective treatments. In the COVID-19 pandemic, despite being a new virus, there are already drugs suggested as active in in vitro assays that are being repurposed in clinical trials. Promising SARS-CoV-2 viral targets and computational approaches are described and discussed. Here, we propose, based on open antiviral drug discovery approaches for previous outbreaks, that there could still be gaps in our approach to drug discovery.

    Search related documents:
    Co phrase search for related documents
    • active compound and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • active show and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • actual outbreak and acute respiratory syndrome: 1, 2
    • acute respiratory syndrome and additional drug: 1, 2, 3, 4, 5, 6
    • acute respiratory syndrome and additional treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and additional treatment identify: 1
    • acute respiratory syndrome and loop region: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute respiratory syndrome and lopinavir loperamide: 1
    • acute respiratory syndrome and lopinavir loperamide chlorpromazine: 1
    • acute respiratory syndrome and lopinavir loperamide chlorpromazine chloroquine: 1